UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome

Pediatrics (Evanston), 2002-06, Vol.109 (6), p.1081-1087

2002

Volltextzugriff (PDF)

Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys

Pediatric research, 1996-04, Vol.39 (4), p.715-724

1996

Volltextzugriff (PDF)

Bronchopulmonary segmental lavage with Surfaxin (KL4-surfactant) for acute respiratory distress syndrome

American journal of respiratory and critical care medicine, 1999-10, Vol.160 (4), p.1188-1195

1999

Volltextzugriff (PDF)

Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome

Pediatric research, 1998-11, Vol.44 (5), p.705-715

1998

Volltextzugriff (PDF)

Surfactant Lavage Treatment in a Model of Respiratory Distress Syndrome

Chest, 1999-07, Vol.116 (1 Suppl), p.85S-86S

1999

Volltextzugriff (PDF)

The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants

Pediatric research, 1991-05, Vol.29 (5), p.460-465

1991

Volltextzugriff (PDF)

Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies

Biochemistry (Easton), 1993-08, Vol.32 (32), p.8228-8238

1993

Volltextzugriff (PDF)

Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B

Biochemistry (Easton), 1991-08, Vol.30 (34), p.8395-8401

1991

Volltextzugriff (PDF)

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome

American journal of respiratory and critical care medicine, 1996-01, Vol.153 (1), p.404-410

1996

Volltextzugriff (PDF)

Protein-Phospholipid Interactions in Pulmonary Surfactant

Chest, 1994-03, Vol.105 (3), p.57S-62S

1994

Volltextzugriff (PDF)

The Therapeutic Effect of Bronchoalveolar Lavage with KL4-Surfactant in Animal Models of Meconium Aspiration Syndrome. † 1578

Pediatric research, 1997-04, Vol.41, p.265-265

1997

Volltextzugriff (PDF)

The Binding and Cleavage Characteristics of Human Hageman Factor during Contact Activation

The Journal of clinical investigation, 1977-06, Vol.59 (6), p.1167-1175

1977

Volltextzugriff (PDF)

The relationship between PF-DIL and activated human Hageman factor

The Journal of immunology (1950), 1974-07, Vol.113 (1), p.103-109

1974

Volltextzugriff (PDF)

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen

The Journal of clinical investigation, 1977-06, Vol.59 (6), p.1167-1175

1977

Volltextzugriff (PDF)

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

The Journal of experimental medicine, 1978-03, Vol.147 (3), p.719-729

1978

Volltextzugriff (PDF)

Structural changes accompanying enzymatic activation of human Hageman factor

The Journal of clinical investigation, 1974-09, Vol.54 (3), p.619-627

1974

Volltextzugriff (PDF)

The plasma contact system in atopic asthma

Journal of allergy and clinical immunology, 1983-07, Vol.72 (1), p.83-88

1983

Volltextzugriff (PDF)

Biochemical Factors in Pulmonary Inflammatory Disease

Chest, 1983-05, Vol.83 (5), p.67S-70S

1983

Volltextzugriff (PDF)

The interaction of Hageman factor and immune complexes

The Journal of clinical investigation, 1972-10, Vol.51 (10), p.2736-2745

1972

Volltextzugriff (PDF)

Biochemical events associated with pulmonary failure in shock and trauma

Journal of burn care & rehabilitation, 1987-11, Vol.8 (6), p.536-542

1987

Volltextzugriff (PDF)

Activation of the Hageman Factor-Dependent Systems during IgE-Mediated Reactions of the Human Lung

International archives of allergy and immunology, 1981, Vol.66 (Suppl. 1), p.165-167

1981

Volltextzugriff (PDF)

Soluble mediators of injury of the microvasculature: Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems

Microvascular research, 1974-07, Vol.8 (1), p.112-121

1974

Volltextzugriff (PDF)

The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulation

Clinical immunology and immunopathology, 1980-01, Vol.15 (3), p.367-374

1980

Volltextzugriff (PDF)

Human surfactant treatment of severe respiratory distress syndrome: Pulmonary effluent indicators of lung inflammation

The Journal of pediatrics, 1986-05, Vol.108 (5), p.741-748

1986

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome

Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys

Bronchopulmonary segmental lavage with Surfaxin (KL4-surfactant) for acute respiratory distress syndrome

Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome

Surfactant Lavage Treatment in a Model of Respiratory Distress Syndrome

The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants

Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies

Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome

Protein-Phospholipid Interactions in Pulmonary Surfactant

The Therapeutic Effect of Bronchoalveolar Lavage with KL4-Surfactant in Animal Models of Meconium Aspiration Syndrome. † 1578

The Binding and Cleavage Characteristics of Human Hageman Factor during Contact Activation

The relationship between PF-DIL and activated human Hageman factor

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

Structural changes accompanying enzymatic activation of human Hageman factor

The plasma contact system in atopic asthma

Biochemical Factors in Pulmonary Inflammatory Disease

The interaction of Hageman factor and immune complexes

Biochemical events associated with pulmonary failure in shock and trauma

Activation of the Hageman Factor-Dependent Systems during IgE-Mediated Reactions of the Human Lung

Soluble mediators of injury of the microvasculature: Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems

The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulation

Human surfactant treatment of severe respiratory distress syndrome: Pulmonary effluent indicators of lung inflammation

Suchergebnisse filtern